Celyad Competitors and Similar CompaniesClear all
Celyad's competitors and similar companies include Moderna.
 Celyad Celyad is a biopharmaceutical company focused on the discovery and development of regenerative and protective therapies in cardiology and oncology. |  Moderna Moderna (formerly Moderna Therapeutics) is a biotechnology company focused on messenger RNA (mRNA) medicine. | |
Founding Date | Founding Date 2007 | Founding Date 2010 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Mont-Saint-Guibert, BE HQ New York, US | |
Employees | Employees 17 | Employees 5,8004% increase |
Valuation ($) | Valuation ($) 11.8 m | Valuation ($) 21.2 b |
Financial | ||
Revenue (est.) | Revenue (est.) €21k (FY, 2025) | Revenue (est.) $1.9b (FY, 2025) |
Cost of goods | Cost of goods €8k (FY, 2025) | Cost of goods $868m (FY, 2025) |
Gross profit | Gross profit €5.9m (FY, 2025) | Gross profit $1.1b (FY, 2025) |
Net income | Net income €830k (FY, 2025) | Net income ($2.8b) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Moderna
HQ
Cambridge, US
Employees
5,800↑ 4% increase
Moderna (formerly Moderna Therapeutics) is a biotechnology company focused on messenger RNA (mRNA) medicine.
View company